Uploads:
- Deliverable 5.3 Scoping paper on the development of an indicator on chemical exposure in the European population Info
- Deliverable 5.2 1st substance-group specific derivation of EU-wide health-based guidance values Info
- Additional Deliverable 5.1 A (phased) plan for action: how structured multi-actor dialogues on human biomonitoring results can facilitate targeted policy action (generic canvas for HBM4EU) Info
- Deliverable 5.1 Human biomonitoring in risk assessment: analysis of the current practice and 1st examples on the use of HBM in risk assessments of HBM4EU priority chemicals Info
- Deliverable 14.3 Report on available biomarkers of effect of utility in human epidemiological studies for the 1st set of prioritised substances Info
- Deliverable 10.4 1st annual list of exposure distributions and/or European reference values Info
- Deliverable 16.2 Workflow for screening emerging chemicals Info
- Deliverable 15.3 Report real-life exposure profiles from re-analysis of existing HBM mixture data Info
- Additional Deliverable 14.4 First report on the state of development of new biomarkers of effect Info
- Deliverable 12.3 Biological half-life and internal dosimetry of the 1st set of priority compounds Info
- Additional deliverable 7.2 Literature research and concept for a sample quality study on impact of thawing and freezing on integrity of human samples for selected 1st and 2nd priority substances Info
- Deliverable 6.3 Consultation on a sustainable HBM initiative in Europe Info
- Deliverable 7.5 Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances Info
- Deliverable 8.3 First report on targeted new fieldwork study results Info
- Deliverable 4.5 Second list of HBM4EU priority substances and Chemical Substance Group Leaders for 2019-2021 Info
- Deliverable Report 4.4 - First report on the stakeholder consultation and the mapping of needs Info
- Additional Deliverable 14.2 Granada Workshop: Effect biomarkers & establishing exposure and health relationships Info
- Additional Deliverable 9.1 General guidance for new method development within HBM4EU and role of task 9.3 therein Info
- Deliverable 7.4 1st material for communication to participants, including informed consent Info
- Deliverable 8.1 Description of the national programs A strategy to collect EU wide HBM data Info
- Deliverable 11.1 Report on opportunities and obstacles of combining HBM and health studies, availability of health studies with biological samples, availability of administrative registers, and guidelines for combining HBM and health studies Info
- Deliverable 13.2 Template for AOP update report for selected priority substances Info
- Additional Deliverable 16.3 Direct effect based approaches applied to the screening of emerging substances Info
- Additional Deliverable 16.1 Screening methods inventory Info
- Deliverable 16.1 Prioritised list of known emerging chemicals Info
- Additional Deliverable 15.3 HBM mixture database description and proposal statistical analysis plan Info
- Deliverable 14.1 Criteria for prioritisation of biomarkers of effect Info
- Deliverable 13.1 Criteria for the selection of cohort studies, June 2017 Info
- Additional Deliverable 12.2 Roadmap for model PBTK/D model refinement and analysis for priority substances Info
- Deliverable 12.2 Report on the optimal methodology for exposure reconstruction from HBM data Info
- Additional Deliverable 12.1 Database of exposure-related and ancillary data for priority substances Info
- Additional Deliverable 11.2 Criteria for feasibility studies Info
- Additional Deliverable 11.1 How can the results from BRIDGE Health be incorporated to the work of HBM4EU? Info
- Deliverable 10.2 Statistical Analysis Plan Info
- Annex to Deliverable 10.1 Data Policy, July 2017 Info
- Deliverable 10.1 Data Management Plan, July 2017 Info
- Deliverable 9.4 The Quality Assurance/Quality Control Scheme in the HBM4EU project Info
- Deliverable 9.3 Database of candidate laboratories for the 1st prioritisation round of substances Info
- Deliverable 9.2 Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritisation round of substances Info
- Deliverable 9.1 Criteria for the prioritisation of biomarkers, April 2017 Info
- Additional Deliverable AD 8.2 Research plan for chromates study under HBM4EU Info
- Additional deliverable 8.1 Report on access to occupational data Info
- Deliverable 7.3 1st prioritisation Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and sampling Info
- Deliverable 7.2 Strategy and SOPs for human sample exchange, including ethical demands Info
- Deliverable 7.1 Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM Info
- Deliverable 6.1 First set of key indicators for HBM4EU, June 2017 Info
- Deliverable 4.3 Prioritisation strategy and criteria Info
- Deliverable 4.2 Scoping documents on HBM4EU priority substances for 2018, June 2017 Info
- Deliverable 4.1 Template for the submission of rapid requests, May 2017 Info
- Deliverable 2.4 2018 Programme of training activities, materials and capacity building mechanisms Info
- Deliverable 2.3 2018 Strategy for the communication and dissemination of HBM4EU results Info
- Deliverable 2.2 Strategy for the communication and dissemination of HBM4EU results, March 2017 Info
- Deliverable 2.1 HBM4EU Website, March 2017 Info
- Deliverable 1.8 Establishment of Stakeholder Forum and Advisory Board Info
- Deliverable 1.2 Establishment of Governing Board, August 2019 Info
- Grant agreement, November 2016 Info
Questions:
Answers:
Disclaimer
The HBM4EU project was launched in 2016 with the aim of improving the collective understanding of human exposure to hazardous chemicals and developing HBM as an exposure assessment method. The project had €74m in funding and jointly implemented by 120 partners from 28 participating countries – 24 EU member states plus Norway, Switzerland, Iceland and Israel and the European Environment Agency. One of its aims was to ensure the sustainability of HBM in the EU beyond 2021. The project ended in June 2022. The website will not be updated any longer, except the page on peer reviewed publications, but will be online until 2032.
